Literature DB >> 29678262

Tolfenamic Acid.

Sofia Ahmed1, Muhammad Ali Sheraz1, Iqbal Ahmad1.   

Abstract

Tolfenamic acid (TA) is a nonsteroidal antiinflammatory drug and belongs to the group of fenamates. It is used as a potent pain reliever in the treatment of acute migraine attacks, and disorders like dysmenorrhea, rheumatoid, and osteoarthritis. TA has shown excellent in vitro antibacterial activity against certain ATCC strains of bacteria when complexed with bismuth(III). It has also been reported to block pathological processes associated with Alzheimer's disease. In the recent past, TA has also been used as a novel anticancer agent for the treatment of various cancers. In view of the clinical importance of TA, a comprehensive review of the physical and pharmaceutical properties and details of the various analytical methods used for the assay of the drug in pharmaceutical and biological systems has been made. The methods reviewed include identification tests and titrimetric, spectrophotometric, chromatographic, electrochemical, thermal, microscopic, enzymatic, and solid-state techniques. Along with the analytical profile, the stability and degradation of TA, its pharmacology and pharmacokinetics, dosage forms and dose, adverse effects and toxicity, and interactions have been discussed.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Analysis; Dissolution; Pharmacological aspects; Physical properties; Stability; Synthesis; Tolfenamic acid

Mesh:

Substances:

Year:  2018        PMID: 29678262     DOI: 10.1016/bs.podrm.2018.01.001

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN: 1871-5125


  3 in total

1.  Tolfenamic acid inhibits ROS-generating oxidase Nox1-regulated p53 activity in intrastriatal injection of malonic acid rats.

Authors:  Xin Yang; Heling Zhang; Tong Qu; Yi Wang; Yongxian Zhong; Yuchen Yan; Xuefei Ji; Tiayan Chi; Peng Liu; Libo Zou
Journal:  J Physiol Sci       Date:  2022-07-18       Impact factor: 2.257

2.  The Inclusion of Tolfenamic Acid into Cyclodextrins Stimulated by Microenvironmental pH Modification as a Way to Increase the Anti-Migraine Effect.

Authors:  Anna Stasiłowicz; Ewa Tykarska; Natalia Rosiak; Kinga Sałat; Anna Furgała-Wojas; Tomasz Plech; Kornelia Lewandowska; Katarzyna Pikosz; Kamil Pawłowicz; Judyta Cielecka-Piontek
Journal:  J Pain Res       Date:  2021-04-14       Impact factor: 3.133

3.  Electromagnetic Shielding by MXene-Graphene-PVDF Composite with Hydrophobic, Lightweight and Flexible Graphene Coated Fabric.

Authors:  Kanthasamy Raagulan; Ramanaskanda Braveenth; Hee Jung Jang; Yun Seon Lee; Cheol-Min Yang; Bo Mi Kim; Jai Jung Moon; Kyu Yun Chai
Journal:  Materials (Basel)       Date:  2018-09-22       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.